Evidence Hub

Targeting Serotonin 5-HT2A Receptors in the Treatment of Aggression: from Antipsychotics to Psychedelics

Scheggi S, Braccagni G, Branca C, Bortolato M

Aggression and violent behavior, 2026

Abstract

Aggression, anger, and irritability emerge from dysregulated interactions between prefrontal and limbic circuits, with serotonin (5-HT) exerting a central regulatory influence. Among serotonergic targets, the 5-HT2A receptor has emerged as a key modulator of aggressive behavior. Convergent neuroimaging, postmortem, and preclinical studies consistently implicate heightened prefrontal 5-HT2A receptor levels in reactive aggression and antisocial behavior. In this review, we examine how 5-HT2A receptor function shapes the pathophysiology of aggression and synthesize the pharmacological evidence that informs its therapeutic relevance. Antagonists at the 5-HT2A receptor, including atypical antipsychotics, reliably reduce aggression and irritability across a range of neuropsychiatric disorders. By contrast, the effects of 5-HT2A agonists are more complex. Classic psychedelics have been linked to reduced aggression and improved emotional regulation in several epidemiological and experimental studies, whereas other agonists can heighten irritability or provoke violent behaviors depending on dose, environmental context, and pharmacodynamic properties. These divergent outcomes likely reflect the receptor's intricate molecular architecture, which supports multiple intracellular pathways, ligand-specific signaling biases, heteromeric interactions, and region- and cell-type-specific expression patterns. In the final section, we outline the key unresolved questions that emerge from this…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free